XML 17 R6.htm IDEA: XBRL DOCUMENT
v3.21.2

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($) | Preferred Stock [Member] Series D Convertible Preferred Stock [Member] | Common stock No Par Value [Member] | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total
--- | --- | --- | --- | --- | --- | ---
Beginning balance, value at Nov. 30, 2019 |  |  | $ 3,806 | $ 36,848,063 | $ (38,578,232) | $ (1,726,363)
Beginning balance, shares at Nov. 30, 2019 |  |  | 14,688,726 |  |  |
Common shares issued for the acquisition of Supera Pharmaceuticals, Inc. a company under common control |  |  |  |  | (605,089) | (605,089)
Common Shares Issued For Acquisition Value, Shares |  |  | 13,096,640 |  |  |
Effect of the adoption of Topic 842 effective as of January 1, 2019 |  |  |  |  | (1,379) | (1,379)
Ending balance, value at Dec. 31, 2019 |  |  | $ 3,806 | 36,848,063 | (39,184,700.00) | (2,332,831.00)
Ending balance, shares at Dec. 31, 2019 |  |  | 27,785,366 |  |  |
Private placement of common shares |  |  |  | 650,000 |  | 650,000
Private placement of common shares, shares |  |  | 250,835 |  |  |
Net loss |  |  |  |  | (981,949) | (981,949)
Ending balance, value at Mar. 31, 2020 |  |  | $ 3,806 | 37,498,063 | (40,166,649) | (2,664,780)
Ending balance, shares at Mar. 31, 2020 |  |  | 28,036,201 |  |  |
Beginning balance, value at Dec. 31, 2019 |  |  | $ 3,806 | 36,848,063 | (39,184,700.00) | (2,332,831.00)
Beginning balance, shares at Dec. 31, 2019 |  |  | 27,785,366 |  |  |
Net loss |  |  |  |  |  | (5,199,758)
Ending balance, value at Sep. 30, 2020 |  |  | $ 3,806 | 40,614,836 | (44,384,458) | (3,765,816)
Ending balance, shares at Sep. 30, 2020 |  |  | 28,551,379 |  |  |
Beginning balance, value at Mar. 31, 2020 |  |  | $ 3,806 | 37,498,063 | (40,166,649) | (2,664,780)
Beginning balance, shares at Mar. 31, 2020 |  |  | 28,036,201 |  |  |
Stock based compensation for services |  |  |  | 14,800 |  | 14,800
Stock based compensation for services, shares |  |  | 1,930 |  |  |
Stock options issued for debt issuance |  |  |  | 693,450 |  | 693,450
Net loss |  |  |  |  | (1,094,909) | (1,094,909)
Ending balance, value at Jun. 30, 2020 |  |  | $ 3,806 | 38,206,313 | (41,261,558) | (3,051,439)
Ending balance, shares at Jun. 30, 2020 |  |  | 28,038,131 |  |  |
Private placement of common shares |  |  |  | 1,330,000 |  | 1,330,000
Private placement of common shares, shares |  |  | 513,248 |  |  |
Stock options issued for debt issuance |  |  |  | $ 273,935 |  | $ 273,935
Stock options issued for services |  |  |  | 804,588 |  | 804,588
Net loss |  |  |  |  | $ (3,122,900) | $ (3,122,900)
Ending balance, value at Sep. 30, 2020 |  |  | $ 3,806 | 40,614,836 | (44,384,458) | (3,765,816)
Ending balance, shares at Sep. 30, 2020 |  |  | 28,551,379 |  |  |
Beginning balance, value at Dec. 31, 2020 |  |  | $ 4,004 | 43,411,487 | (48,672,525) | (5,257,034)
Beginning balance, shares at Dec. 31, 2020 |  |  | 28,553,307 |  |  |
Reverse merger with Akers Biosciences Inc effective April 16, 2021 |  |  |  |  |  |
Modification of the terms of 4,188,315 pre-merger MyMD stock options per the terms of the merger agreement |  |  |  |  |  |
Exercise of prepaid equity forward contracts for common stock |  |  |  |  |  |
Exercise of prepaid equity forward contracts for common stock, shares |  |  |  |  |  |
Common shares issued for the acquisition of Supera Pharmaceuticals, Inc. a company under common control |  |  |  |  |  |
Common Shares Issued For Acquisition Value, Shares |  |  |  |  |  |
Effect of the adoption of Topic 842 effective as of January 1, 2019 |  |  |  |  |  |
Stock based compensation for services |  |  |  |  |  |
Stock based compensation for services, shares |  |  |  |  |  |
Exercise of warrants for common stock |  |  |  |  |  |
Exercise of warrants for common stock, shares |  |  |  |  |  |
Net loss |  |  |  |  | $ (3,089,704) | $ (3,089,704)
Ending balance, value at Mar. 31, 2021 |  |  | $ 4,004 | 43,411,487 | (51,762,229) | (8,346,738)
Ending balance, shares at Mar. 31, 2021 |  |  | 28,553,307 |  |  |
Beginning balance, value at Dec. 31, 2020 |  |  | $ 4,004 | 43,411,487 | (48,672,525) | (5,257,034)
Beginning balance, shares at Dec. 31, 2020 |  |  | 28,553,307 |  |  |
Net loss |  |  |  |  |  | (26,649,321)
Ending balance, value at Sep. 30, 2021 | $ 144,524 | 101,069,246 |  |  | (75,321,846) | 25,891,924
Ending balance, shares at Sep. 30, 2021 | 72,992 |  | 37,419,774 |  |  |
Beginning balance, value at Mar. 31, 2021 |  |  | $ 4,004 | 43,411,487 | (51,762,229) | (8,346,738)
Beginning balance, shares at Mar. 31, 2021 |  |  | 28,553,307 |  |  |
Reverse merger with Akers Biosciences Inc effective April 16, 2021, shares | 72,992 |  | 8,335,627 |  |  |
Modification of the terms of 4,188,315 pre-merger MyMD stock options per the terms of the merger agreement |  | 15,036,051 |  |  |  | 15,036,051
Exercise of prepaid equity forward contracts for common stock |  |  |  |  |  |
Exercise of prepaid equity forward contracts for common stock, shares |  |  | 466,716 |  |  |
Net loss |  |  |  |  | (18,092,336) | (18,092,336)
Reverse merger with Akers Biosciences Inc effective April 16, 2021 | 144,524 | 85,748,325 | (4,004) | (43,411,487) |  | 42,477,358
Ending balance, value at Jun. 30, 2021 | $ 144,524 | 100,784,376 |  |  | (69,854,565) | 31,074,335
Ending balance, shares at Jun. 30, 2021 | 72,992 |  | 37,355,650 |  |  |
Stock based compensation for services |  | 90,002 |  |  |  | 90,002
Stock based compensation for services, shares |  |  | 16,826 |  |  |
Exercise of warrants for common stock |  | 194,868 |  |  |  | 194,868
Exercise of warrants for common stock, shares |  |  | 47,298 |  |  |
Net loss |  |  |  |  | (5,467,281) | (5,467,281)
Ending balance, value at Sep. 30, 2021 | $ 144,524 | $ 101,069,246 |  |  | $ (75,321,846) | $ 25,891,924
Ending balance, shares at Sep. 30, 2021 | 72,992 |  | 37,419,774 |  |  |

X
- Definition Common Shares Issued For Acquisition Value. + References No definition available. + Details
Name: | MYMD_CommonSharesIssuedForAcquisitionValue
Namespace Prefix: | MYMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Common shares issued for acquisition value share. + References No definition available. + Details
Name: | MYMD_CommonSharesIssuedForAcquisitionValueShare
Namespace Prefix: | MYMD_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cumulative Effect Of Adoption. + References No definition available. + Details
Name: | MYMD_CumulativeEffectOfAdoption
Namespace Prefix: | MYMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Exercise Of Prepaid Equity Forward Contracts For Common Stock. + References No definition available. + Details
Name: | MYMD_ExerciseOfPrepaidEquityForwardContractsForCommonStock
Namespace Prefix: | MYMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Exercise of prepaid equity forward contracts for common stock shares. + References No definition available. + Details
Name: | MYMD_ExerciseOfPrepaidEquityForwardContractsForCommonStockShares
Namespace Prefix: | MYMD_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise of warrants for common stock. + References No definition available. + Details
Name: | MYMD_ExerciseOfWarrantsForCommonStock
Namespace Prefix: | MYMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Exercise of warrants for common stock shares. + References No definition available. + Details
Name: | MYMD_ExerciseOfWarrantsForCommonStockShares
Namespace Prefix: | MYMD_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Modification Terms Of Pre Merger Stock Options. + References No definition available. + Details
Name: | MYMD_ModificationTermsOfPreMergerStockOptions
Namespace Prefix: | MYMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Private placement of common shares. + References No definition available. + Details
Name: | MYMD_PrivatePlacementOfCommonShares
Namespace Prefix: | MYMD_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Private Placement Of Common Shares Value. + References No definition available. + Details
Name: | MYMD_PrivatePlacementOfCommonSharesValue
Namespace Prefix: | MYMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Stock Based Compensation For Services. + References No definition available. + Details
Name: | MYMD_StockBasedCompensationForServices
Namespace Prefix: | MYMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Stock based compensation for services shares. + References No definition available. + Details
Name: | MYMD_StockBasedCompensationForServicesShares
Namespace Prefix: | MYMD_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Stock issued during period value acquisition. + References No definition available. + Details
Name: | MYMD_StockIssuedDuringPeriodValueAcquisition
Namespace Prefix: | MYMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Stock options issued for services. + References No definition available. + Details
Name: | MYMD_StockOptionsIssuedForServices
Namespace Prefix: | MYMD_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase (decrease) in additional paid-in capital (APIC) from recognition of substantial premium at which convertible debt instrument is issued. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1D -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611 + Details
Name: | us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 65 -Paragraph 1 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227 Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756 Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 60B -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1A -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580 Reference 25: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 11 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 11 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1B -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756 Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756 Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756 Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of shares issued which are neither cancelled nor held in the treasury. + References No definition available. + Details
Name: | us-gaap_SharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares of stock issued during the period pursuant to acquisitions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesAcquisitions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of stock issued pursuant to acquisitions during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueAcquisitions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 4.E) -URI http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(31)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612 Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 + Details
Name: | us-gaap_StockholdersEquity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant